Persistent positivity for aPL has been evaluated in patients enrolled in the APS ACTION Registry, which includes patients with or without systemic autoimmune diseases but persistently positive for APS criteria aPL. The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.